22 / 88
22
Scientific Programme /
Sunday, 18 June 2017
WFSBP 2017
SUN
aa
Sunday, 18 June 2017
T2: ANTIDEPRESSANTS: BASIC/ CLINICAL
S-01
SYMPOSIUM
08:30–10:00
Auditorium 10+11+12
Towards novel rapid-acting antidepressants
Chair:
Tomi Rantamäki, Finland
Co-Chair: Gregers Wegener, Denmark
001
Rapid acting antidepressants in chronic pain
Ipek Yalcin, France
002
Morphological and structural alterations following
rapid acting antidepressants
Gregers Wegener, Denmark
003
Antidepressant potential of cannabidiol:
Preclinical evidence
Sâmia Joca, Brazil
004
Anesthetics as rapid-acting antidepressants
Tomi Rantamäki, Finland
T20: LIAISON PSYCHIATRY
S-02
SYMPOSIUM
08:30–10:00
Auditorium 15
Psychiatric services in emergency departments:
Challenges and solutions
Chair:
Ruby Castilla-Puentes, USA
Co-Chair: Tatiana Falcone, USA
001
Psychiatric consultations in rural general
hospitals – Latinos vs. Anglos
Bernardo Ng, USA
002
A study of insomnia and cormobid psychiatric
conditions in rehabilitation clinics
Franklin Escobar, Colombia
003
Depression and medical comorbidity in emergency
departments in Mexico
Ricardo Secin, Mexico
004
Self-inflicted injuri in children and adolescents:
A study in a tertiary care hospital in Santiago de Chile
Arturo Grau, Chile
T1: ADDICTIVE DISORDERS
S-03
SYMPOSIUM
08:30–10:00
Congress Hall A 3
Dissecting the role of the neurotrophin Brain Derived
Neurotrophic Factor in cocaine addiction: Clues from
clinical and preclinical studies
Chair:
Fabio Fumagalli, Italy
001
Acute exposure to cocaine during brain develop-
ment evokes depressive-like behaviors via downregula-
tion of Brain Derived Neurotrophic Factor signaling
Fabio Fumagalli, Italy
002
Cocaine and orbitofrontal cortical Brain Derived
Neurotrophic Factor deficiency induce habit-based
decision-making: Blockade by trkB stimulation
Shannon Gourley, USA
003
Systemic administration of the brain-penetrant
TrkB antagonist cyclotraxin-b reduces short and long
access cocaine intake
Michel Verheij, The Netherlands
004
Brain Derived Neurotrophic Factor and cocaine in
clinical samples: A useful biomarker for treatment?
Lisia von Diemen, Brazil
T51: MISCELLANEOUS
WS-01
WORKSHOP
08:30–10:00
B3 M1-M2
Initiatives from the Spanish Society of Biological
Psychiatry: From evidence to experience
Chair:
Miquel Bernardo, Spain
Co-Chair: Ana Gonzalez Pinto, Spain
001
Agitation consensus
Eduard Vieta, Spain
002
ECT consensus
Mikel Urretavizcaya, Spain
003
Clinical guidelines for adult patients with a severe
mental disorder and a comorbid substance use
Luis San, Spain
FC-01
FREE COMMUNICATION SESSION
08:30–10:00
B3 M3-M4
Treatment of depression
Chair:
Tom Bolwig, Denmark
Co-Chair: Eva Ceskova, Czech Republic
001
Optimization of therapy with antidepressants
Eva Ceskova, Czech Republic
P. Silhán